Literature DB >> 15885638

Correlates of lymphoproliferative responses to measles, mumps, and rubella (MMR) virus vaccines following MMR-II vaccination in healthy children.

Neelam Dhiman1, Inna G Ovsyannikova, Robert M Jacobson, Robert A Vierkant, V Shane Pankratz, Steven J Jacobsen, Gregory A Poland.   

Abstract

Cell-mediated immunity (CMI) to measles, mumps, and rubella viral antigens plays a critical role in providing long-term protection against these infectious diseases. We examined CMI by measuring lymphoproliferative response induced in response to stimulation with the above three antigens following two doses of measles, mumps, and rubella-II (MMR-II) vaccine in a randomly selected, population-based cohort of healthy children. We determined if a correlative and predictive intraclass relationship exists between CMI to the three components of MMR-II. We detected positive lymphoproliferative responses to measles, mumps, and rubella vaccines. Mumps vaccine used as an antigen had the highest median stimulation index followed by measles and rubella vaccines. The overall intraclass correlation value for lymphoproliferative response to measles, mumps, and rubella using Pearson's correlation was 0.61 (95% confidence interval = 0.56, 0.66). We observed a significant pairwise association to individual vaccine components between subjects in the upper and lower 10th percentile of immune response. This study demonstrates recall CMI post-MMR-II vaccination with significant intraclass correlation among the CMI responses to the three vaccine components.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15885638     DOI: 10.1016/j.clim.2004.12.010

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  10 in total

1.  Challenges in Interpretation of Diagnostic Test Results in a Mumps Outbreak in a Highly Vaccinated Population.

Authors:  L A Trotz-Williams; N J Mercer; K Paphitis; J M Walters; D Wallace; E Kristjanson; J Gubbay; T Mazzulli
Journal:  Clin Vaccine Immunol       Date:  2017-02-06

2.  Response to third rubella vaccine dose.

Authors:  Lotta Siira; Hanne Nøkleby; Regine Barlinn; Øystein R Riise; Ingeborg S Aaberge; Susanne G Dudman
Journal:  Hum Vaccin Immunother       Date:  2018-06-21       Impact factor: 3.452

3.  Relationship between HLA polymorphisms and gamma interferon and interleukin-10 cytokine production in healthy individuals after rubella vaccination.

Authors:  Inna G Ovsyannikova; Robert M Jacobson; Jenna E Ryan; Neelam Dhiman; Robert A Vierkant; Gregory A Poland
Journal:  Clin Vaccine Immunol       Date:  2007-01-10

4.  Assessment of humoral and cell-mediated immune response to measles-mumps-rubella vaccine viruses among patients with asthma.

Authors:  Kwang Ha Yoo; Kanishtha Agarwal; Michael Butterfield; Robert M Jacobson; Gregory A Poland; Young J Juhn
Journal:  Allergy Asthma Proc       Date:  2010 Nov-Dec       Impact factor: 2.587

5.  Predominant inflammatory cytokine secretion pattern in response to two doses of live rubella vaccine in healthy vaccinees.

Authors:  Neelam Dhiman; Iana H Haralambieva; Robert A Vierkant; V Shane Pankratz; Jenna E Ryan; Robert M Jacobson; Inna G Ovsyannikova; Gregory A Poland
Journal:  Cytokine       Date:  2010-02-01       Impact factor: 3.861

6.  Immune responses to mumps vaccine in adults who were vaccinated in childhood.

Authors:  Rima Hanna-Wakim; Linda L Yasukawa; Phillip Sung; Ann M Arvin; Hayley A Gans
Journal:  J Infect Dis       Date:  2008-06-15       Impact factor: 5.226

7.  Influence of host genetic variation on rubella-specific T cell cytokine responses following rubella vaccination.

Authors:  Inna G Ovsyannikova; Jenna E Ryan; Robert A Vierkant; Megan M O'Byrne; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  Vaccine       Date:  2009-02-05       Impact factor: 3.641

8.  Immunity to rubella: an Italian retrospective cohort study.

Authors:  Francesco Paolo Bianchi; Sara De Nitto; Pasquale Stefanizzi; Angela Maria Vittoria Larocca; Cinzia Annatea Germinario; Silvio Tafuri
Journal:  BMC Public Health       Date:  2019-11-08       Impact factor: 3.295

Review 9.  Mumps Outbreaks in Vaccinated Populations-Is It Time to Re-assess the Clinical Efficacy of Vaccines?

Authors:  Anna R Connell; Jeff Connell; T Ronan Leahy; Jaythoon Hassan
Journal:  Front Immunol       Date:  2020-09-18       Impact factor: 7.561

10.  Long-term Immunogenicity of Measles Vaccine: An Italian Retrospective Cohort Study.

Authors:  Francesco Paolo Bianchi; Pasquale Stefanizzi; Sara De Nitto; Angela Maria Vittoria Larocca; Cinzia Germinario; Silvio Tafuri
Journal:  J Infect Dis       Date:  2020-02-18       Impact factor: 7.759

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.